Canakinumab in the routinary clinical practice in cryopyrin-associated periodic syndromes (CAPS): one year of follow-up

Benzer Materyaller

• Canakinumab in the routinary clinical practice in cryopyrin-associated periodic syndromes (CAPS): one year of follow-up
  Yazar:: Martini A, ve diğerleri
  Baskı/Yayın Bilgisi: (2011-09-01)
• National CAPS (Cryopyrin-Associated Periodic Syndrome) Registry
  Yazar:: Bibalo, C, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• The schedule of administration of canakinumab in cryopyrin associated periodic syndrome is driven by the phenotype severity rather than the age
  Yazar:: Caorsi, Roberta, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• An experience of use of canakinumab IL-1 inhibitor in children with cryopyrin-associated periodic syndromes (CAPS)
  Yazar:: Salugina, Svetlana O, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Dosing patterns of canakinumab in patients with Cryopyrin-Associated Periodic Syndromes (CAPS): A comparative analysis of a study in Western versus Japanese patients
  Yazar:: Bader-Meunier, B, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)